GlassScriptPhysician profile
Christopher S Fukuda
NPI 1922089721
$18,873.81
in general payments reported to CMS, 2019-2025
28 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $309 · 2021: $2,733 · 2022: $14K · 2023: $305 · 2024: $525 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.72 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,452.23 | 2022 | |
| Axonics, INC. | $3,773.83 | 2020-2024 | Axonics |
| Astellas Pharma US INC | $480.53 | 2019-2024 | Xtandi |
| Boston Scientific Corporation | $166.17 | 2019-2025 | Axonics, Greenlight Xps, Rezum Generator |
| Endo Pharmaceuticals INC. | $162.81 | 2019-2020 | |
| Allergan, INC. | $126.68 | 2019-2021 | |
| Abbvie INC. | $112.33 | 2019-2024 | |
| Tolmar Pharmaceuticals, INC. | $80.89 | 2019-2020 | |
| Medtronic, INC. | $53.08 | 2021 | |
| Janssen Biotech, INC. | $50.24 | 2019-2022 | |
| Amgen INC. | $38.64 | 2019 | |
| Sumitomo Pharma America, INC. | $37.02 | 2024 | Orgovyx |
| Vifor Pharma, INC. | $31.61 | 2022 | |
| Merck Sharp & Dohme LLC | $30.84 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.07 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $29.60 | 2019 | |
| Pfizer INC. | $26.59 | 2019-2020 | |
| Myovant Sciences INC. | $25.52 | 2021 | |
| Laborie Medical Technologies Corp. | $25.21 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Hologic Sales and Service, LLC | $19.90 | 2023 | Thinprep 2000 Processor |
| Alnylam Pharmaceuticals INC. | $19.68 | 2024 | Oxlumo |
| Calyxo, INC. | $18.75 | 2025 | Cvac Aspiration System |
| Teleflex LLC | $18.15 | 2023 | Urolift |
| 180 Medical, INC. | $14.27 | 2019 | |
| Calliditas Therapeutics US INC. | $14.08 | 2024 | |
| Neotract INC. | $13.05 | 2019 | |
| Myriad Genetic Laboratories, INC. | $11.24 | 2021 | |
| Rgh Enterprises LLC | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Fukuda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.